CN111632075B - Exosome preparation for promoting skin wound healing and preparation method thereof - Google Patents

Exosome preparation for promoting skin wound healing and preparation method thereof Download PDF

Info

Publication number
CN111632075B
CN111632075B CN202010462102.0A CN202010462102A CN111632075B CN 111632075 B CN111632075 B CN 111632075B CN 202010462102 A CN202010462102 A CN 202010462102A CN 111632075 B CN111632075 B CN 111632075B
Authority
CN
China
Prior art keywords
parts
preparation
exosome
extract
extracting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010462102.0A
Other languages
Chinese (zh)
Other versions
CN111632075A (en
Inventor
冯焯威
陈镇洲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Sailang Biotechnology Co ltd
Original Assignee
Guangzhou Sailang Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Sailang Biotechnology Co ltd filed Critical Guangzhou Sailang Biotechnology Co ltd
Priority to CN202010462102.0A priority Critical patent/CN111632075B/en
Publication of CN111632075A publication Critical patent/CN111632075A/en
Application granted granted Critical
Publication of CN111632075B publication Critical patent/CN111632075B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/24Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to an exosome preparation for promoting skin wound healing and a preparation method thereof, belonging to the technical field of stem cells. An exosome preparation for promoting skin wound healing comprises the following components in parts by mass: 30-50 parts of a dry cell exosome extract, 10-20 parts of a basjoo flower extracting solution, 10-20 parts of a witch hazel extract and 10-20 parts of a chamomile extract. The preparation method is simple, and the raw materials are uniformly mixed according to the mass part ratio. According to the invention, the stem cell exosome and the components such as basjoo flower, chamomile, witch hazel, alginate are added, so that the wound surface hemostasis is accelerated, and the damaged tissue repair and skin regeneration are promoted; meanwhile, the product has the effects of resisting inflammation, inhibiting bacteria, relieving itching and moisturizing. Has the characteristics of good product effect, quick response, convenient use, no irritation to skin mucosa, safety, reliability and no scar.

Description

Exosome preparation for promoting skin wound healing and preparation method thereof
Technical Field
The invention belongs to the technical field of stem cells, and particularly relates to an exosome preparation for promoting skin wound healing and a preparation method thereof.
Background
Exosomes are vesicle produced by cells through a series of biological mechanisms such as endocytosis, fusion and efflux, and are excluded from the cells through active secretion, and are lipid bilayers in nature. The exosome contains miRNA and various molecular proteins and participates in regulating various physiological functions of cells. Exosomes can play a role in the treatment of various diseases by virtue of the therapeutic efficacy of carried biologically active substances such as proteins and mirnas with street stem cells. Research shows that the exosome has the effects of inhibiting inflammation, promoting skin cell proliferation and blood vessel regeneration and reducing myofibroblast accumulation, repairs injury through a paracrine mode, and provides a new method for treating skin injury.
Skin wounds are injuries encountered in daily life, particularly skin burns and scalds of varying degrees. The wound skin has slow healing process, is easy to cause infection if not treated properly, is easy to form scars, influences the appearance and brings great trouble to people. Most of the existing products for treating burns, scalds, traumas and the like only have the effects of easing pain and diminishing inflammation, the skin injury is healed slowly, and scars are easy to remain in the later period.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide an exosome preparation which does not leave scars, has the functions of resisting bacteria and diminishing inflammation and has quick response and promoting the healing of skin wounds and a preparation method thereof.
In order to achieve the purpose, the invention adopts the technical scheme that:
an exosome preparation for promoting skin wound healing comprises the following raw materials in parts by mass: 30-50 parts of a dry cell exosome extract, 10-20 parts of a basca flower extracting solution, 10-20 parts of a witch hazel extracting solution and 10-20 parts of a chamomile extracting solution.
In addition, the exosome in the exosome extract can promote the growth and migration of normal and wound fibroblasts, and acts on endothelial cells to induce the generation of blood vessels, and in addition, the exosome contains various regulatory signals, and after the signals are transmitted to the cells, the exosome can activate corresponding signal pathways (such as AKT, ERK1/2, STAT3 and the like), so that the expression of various nutritional factors (such as bFGF, IGF, VEGF and the like) is induced, and the repair of damaged tissues is promoted.
Contains various aromatic alcohol compounds, and has antiinflammatory, antibacterial, antipruritic, moisture keeping and antioxidant effects.
Preferably, the exosome preparation for healing the skin wound comprises the following raw materials in parts by mass: 40 parts of dry cell exosome extract, 15 parts of basjoo flower extract, 15 parts of witch hazel extract, 15 parts of chamomile extract, 0.5 part of allantoin and 0.05 part of alginate.
The exosome preparation with the optimal proportion has excellent wound repair effect while giving consideration to the effects of resisting inflammation, relieving itching and preserving moisture.
Preferably, the stem cell exosome extract comprises mesenchymal stem cell exosomes and mesenchymal stem cell culture supernatant.
Preferably, the preparation method of the stem cell exosome extract is characterized by comprising the following steps of:
(1) carrying out cell culture according to GMP to obtain mesenchymal stem cells;
(2) ultrasonically crushing the mesenchymal stem cells obtained in the step (1) to obtain mesenchymal stem cell exosomes;
(3) collecting the supernatant of the mesenchymal stem cells in the step (1) to obtain a supernatant exosome of the stem cell culture;
(4) and (3) respectively dissolving the mesenchymal stem cell exosomes obtained in the step (2) and the stem cell culture supernatant exosomes obtained in the step (3) in normal saline, and mixing and stirring uniformly in an equal volume to obtain a stem cell exosome extract.
Preferably, the exosome preparation for promoting skin wound healing further comprises the following components in parts by mass: 0.2-1 part of allantoin, 0.05-1 part of alginate, 1-5 parts of PEG-40 hydrogenated castor oil, 0.05-0.1 part of hyaluronic acid, 1-5 parts of butanediol, 0.1-0.3 part of methyl hydroxybenzoate, 0.1-1 part of hydroxyethyl cellulose, 0.05-0.1 part of EDTA-disodium and 4-33 parts of deionized water.
The alginate has the capacity of absorbing a large amount of liquid, can form a layer of stable sodium alginate reticular gel on the surface of a wound, and enables the wound surface to maintain a moist environment, thereby being beneficial to the healing of the wound and the regeneration of the skin, and accelerating the hemostasis of the wound surface; allantoin has the effects of promoting cell growth and accelerating wound healing, and is a good active agent component for treating skin injury.
Preferably, the exosome preparation for promoting skin wound healing further comprises the following components in parts by mass: 0.5 part of allantoin, 0.05 part of alginate, 5 parts of PEG-40 hydrogenated castor oil, 0.05 part of hyaluronic acid, 4 parts of butanediol, 0.1 part of methyl hydroxybenzoate, 0.5 part of hydroxyethyl cellulose, 0.05 part of EDTA-disodium and 4.75 parts of deionized water.
Preferably, the alginate is at least one of sodium alginate, potassium alginate, calcium alginate and ammonium alginate.
Preferably, the preparation method of the basjoo flower extracting solution comprises the following steps:
(1) taking fresh flowers of the ballflower, adding 18 times of 65% ethanol for the first time, and extracting for 1.5 hours; adding 10 times of 60% ethanol for the second time, and extracting for 1.5 hours; adding 8 times of 60% ethanol for the third time, and extracting for 1.5 hr; (2) filtering the extractive solutions extracted for 3 times with gauze, mixing filtrates, and concentrating the filtrate under reduced pressure to 5 times of the weight of flos Bombacis Cannabinae to obtain the extractive solution.
Preferably, the preparation method of the witch hazel extract comprises the following steps:
(1) taking fresh witch hazel, adding 18 times of 65% ethanol for the first time, and extracting for 1.5 hours; adding 10 times of 60% ethanol for the second time, and extracting for 1.5 hours; adding 8 times of 60% ethanol for the third time, and extracting for 1.5 hr; (2) filtering the extractive solutions extracted for 3 times with gauze, mixing filtrates, and concentrating the filtrate under reduced pressure to 5 times of the weight of flos Bombacis Cannabinae to obtain radix Hamamelis mollis extractive solution.
Preferably, the preparation method of the chamomile extracting solution comprises the following steps:
(1) taking fresh chamomile, adding 18 times of 65% ethanol for the first time, and extracting for 1.5 hours; adding 10 times of 60% ethanol for the second time, and extracting for 1.5 hours; adding 8 times of 60% ethanol for the third time, and extracting for 1.5 hr; (2) filtering the extractive solutions extracted for 3 times with gauze, mixing filtrates, and concentrating the filtrate under reduced pressure to 5 times of the weight of flos Bombacis Cannabinae to obtain flos Matricariae Chamomillae extractive solution.
The preparation method of the exosome preparation for promoting the skin wound healing specifically comprises the following steps:
s1 dissolving allantoin, alginate, hyaluronic acid and EDTA-disodium in deionized water, and stirring;
s2, adding butanediol, methyl hydroxybenzoate and hydroxyethyl cellulose into the solution obtained in the step S1 in proportion, and stirring and mixing uniformly;
s3, adding the basjoo flower extracting solution, the witch hazel extracting solution, the chamomile extracting solution and the PEG-40 hydrogenated castor oil into the solution obtained in the step S2, and stirring and mixing uniformly;
s4 adding the extract of the stem cell exosome into the solution obtained in the step S3, and stirring and mixing uniformly to obtain the finished product.
Compared with the prior art, the invention has the beneficial effects that:
(1) the exosome preparation for promoting the healing of the skin wound comprises a stem cell exosome extract which acts on subcutaneous fibroblasts, and focuses on the proliferation and repair of the fibroblasts and the improvement of the microenvironment of peripheral blood vessels; by adding natural plant components and nutrient substances such as the basjoo flower extract, the witch hazel extract and the like, the skin conditioning effects of resisting inflammation, inhibiting bacteria, preserving moisture, whitening and the like are achieved, so that the effect of promoting skin injury repair is achieved, the effect is quick, and no scar is left after the skin conditioning agent is used.
(2) All the raw materials used by the invention are food grade, and the invention does not contain antibiotics and hormones and does not generate toxic or side effect.
Drawings
Fig. 1 is a comparison of a day before and after 15 days of application of an exosome formulation of the present invention to damaged skin.
Detailed Description
To better illustrate the objects, aspects and advantages of the present invention, the present invention will be further described with reference to specific embodiments.
Example 1:
an exosome preparation for promoting skin wound healing comprises the following raw materials in parts by mass: 30 parts of dry cell exosome extract, 10 parts of basjoo flower extract, 10 parts of witch hazel extract, 10 parts of chamomile extract, 0.2 part of allantoin, 0.05 part of alginate, 5 parts of PEG-40 hydrogenated castor oil, 0.05 part of hyaluronic acid, 4 parts of butanediol, 0.1 part of methylparaben, 0.1 part of hydroxyethyl cellulose, 0.1 part of EDTA-disodium and 33 parts of deionized water.
The preparation method of the stem cell exosome extract comprises the following steps:
(1) culturing cells according to GMP, amplifying mesenchymal stem cells by using cell factory equipment, and harvesting to obtain 3 × 10 cells when the cell fusion rate reaches more than 95%8The mesenchymal stem cell of (a);
(2) ultrasonically crushing the mesenchymal stem cells obtained in the step (1) according to the proportion of 1 multiplied by 108Adding the cell amount into 100ml of physiological saline, centrifuging for 10min at 4 ℃ under the condition of 300 Xg to remove cell debris, and collecting supernatant; centrifuging at 4 deg.C and 2500 Xg for 30min to remove apoptotic bodies, and collecting supernatant; then centrifugating for 1h at 4 ℃ under 13000 XgRemoving platelet impurities, and collecting supernatant; finally, centrifuging for 70min under the conditions of 4 ℃ and 100000 Xg to obtain the crushed mesenchymal stem cell exosome;
(3) centrifuging the mesenchymal stem cells in the step (1) for 10min at 4 ℃ under 2000 Xg conditions to remove cell debris, and collecting supernatant; centrifuging at 4 deg.C and 13000 Xg for 1 hr to remove platelet impurities, and collecting supernatant; finally centrifuging for 70min at 4 ℃ under 100000 Xg to obtain a stem cell culture supernatant;
(4) and (3) respectively dissolving the mesenchymal stem cell exosomes obtained in the step (2) and the stem cell culture supernatant exosomes obtained in the step (3) in normal saline, mixing and stirring uniformly in an equal volume, and enabling the concentration of a final protein solution to be 50mg/ml, so as to obtain a stem cell exosome extract.
The preparation method of the basjoo flower extracting solution comprises the following steps:
(1) taking fresh flowers of the ballflower, adding 18 times of 65% ethanol for the first time, and extracting for 1.5 hours; adding 10 times of 60% ethanol for the second time, and extracting for 1.5 hours; adding 8 times of 60% ethanol for the third time, and extracting for 1.5 hr; (2) filtering the extractive solutions extracted for 3 times with gauze, mixing filtrates, and concentrating the filtrate under reduced pressure to 5 times of the weight of flos Bombacis Cannabinae to obtain flos Bombacis Cannabinae extractive solution;
the preparation method of the witch hazel extract comprises the following steps:
(1) taking fresh witch hazel, adding 18 times of 65% ethanol for the first time, and extracting for 1.5 hours; adding 10 times of 60% ethanol for the second time, and extracting for 1.5 hours; adding 8 times of 60% ethanol for the third time, and extracting for 1.5 hr; (2) filtering the extractive solutions extracted for 3 times with gauze, mixing filtrates, and concentrating the filtrate under reduced pressure to 5 times of the weight of flos Bombacis Cannabinae to obtain radix Hamamelis mollis extractive solution;
the preparation method of the chamomile extracting solution comprises the following steps:
(1) taking fresh chamomile, adding 18 times of 65% ethanol for the first time, and extracting for 1.5 hours; adding 10 times of 60% ethanol for the second time, and extracting for 1.5 hours; adding 8 times of 60% ethanol for the third time, and extracting for 1.5 hr; (2) filtering the extractive solutions extracted for 3 times with gauze, mixing filtrates, and concentrating the filtrate under reduced pressure to 5 times of the weight of flos Bombacis Cannabinae to obtain flos Matricariae Chamomillae extractive solution.
The preparation method of the exosome preparation for promoting the healing of the skin wound comprises the following steps:
s1 dissolving allantoin, alginate, hyaluronic acid and EDTA-disodium in deionized water, and stirring;
s2, adding butanediol, methyl hydroxybenzoate and hydroxyethyl cellulose into the solution obtained in the step S1 in proportion, and stirring and mixing uniformly;
s3, adding the basjoo flower extracting solution, the witch hazel extracting solution, the chamomile extracting solution and the PEG-40 hydrogenated castor oil into the solution obtained in the step S2 according to a proportion, and stirring and mixing uniformly;
s4 adding the extract of the stem cell exosome into the solution obtained in the step S3 according to a certain proportion, and stirring and mixing uniformly to obtain a finished product.
Example 2:
an exosome preparation for promoting skin wound healing comprises the following raw materials in parts by mass: 30 parts of dry cell exosome extract, 20 parts of basjoo flower extract, 20 parts of witch hazel extract, 20 parts of chamomile extract, 0.3 part of allantoin, 0.08 part of alginate, 2 parts of PEG-40 hydrogenated castor oil, 0.08 part of hyaluronic acid, 1 part of butanediol, 0.1 part of methylparaben, 0.5 part of hydroxyethyl cellulose, 0.05 part of EDTA-disodium and 4 parts of deionized water.
The extract of the exosome of the stem cell, the extract of basjoa flower, the extract of hamamelis virginiana and the extract of chamomile were prepared according to the preparation method in example 1.
The preparation method of the exosome preparation for promoting the healing of the skin wound comprises the following steps:
s1 dissolving allantoin, alginate, hyaluronic acid and EDTA-disodium in deionized water, and stirring;
s2, adding butanediol, methyl hydroxybenzoate and hydroxyethyl cellulose into the solution obtained in the step S1 in proportion, and stirring and mixing uniformly;
s3, adding the basjoo flower extracting solution, the witch hazel extracting solution, the chamomile extracting solution and the PEG-40 hydrogenated castor oil into the solution obtained in the step S2 according to a proportion, and stirring and mixing uniformly;
s4 adding the extract of the stem cell exosome into the solution obtained in the step S3 according to a certain proportion, and stirring and mixing uniformly to obtain a finished product.
Example 3:
an exosome preparation for promoting skin wound healing comprises the following raw materials in parts by mass: 50 parts of dry cell exosome extract, 10 parts of basjoo flower extract, 10 parts of witch hazel extract, 10 parts of chamomile extract, 1 part of allantoin, 1 part of alginate, 1 part of PEG-40 hydrogenated castor oil, 0.1 part of hyaluronic acid, 5 parts of butanediol, 0.3 part of methylparaben, 1 part of hydroxyethyl cellulose, 0.1 part of EDTA-disodium and 11 parts of deionized water.
The extract of the exosome of the stem cell, the extract of basjoa flower, the extract of hamamelis virginiana and the extract of chamomile were prepared according to the preparation method in example 1.
The preparation method of the exosome preparation for promoting the healing of the skin wound comprises the following steps:
s1 dissolving allantoin, alginate, hyaluronic acid and EDTA-disodium in deionized water, and stirring;
s2, adding butanediol, methyl hydroxybenzoate and hydroxyethyl cellulose into the solution obtained in the step S1 in proportion, and stirring and mixing uniformly;
s3, adding the basjoo flower extracting solution, the witch hazel extracting solution, the chamomile extracting solution and the PEG-40 hydrogenated castor oil into the solution obtained in the step S2 according to a proportion, and stirring and mixing uniformly;
s4 adding the extract of the stem cell exosome into the solution obtained in the step S3 according to a certain proportion, and stirring and mixing uniformly to obtain a finished product.
Experimental example 1: physical and chemical indexes
The characteristics are as follows: the product is a slightly yellowish, transparent, clear and thick emulsion.
And (3) quality detection: the product is randomly sampled and stored at the temperature of 4-25 ℃, and the sensory evaluation of color, clarity and smell is not obviously changed after 1, 3, 6, 9 and 12 months of storage respectively, which shows that the product is stable in property within 12 months after being unpacked and used.
Skin patch test detection: and (4) selecting qualified patch materials, and attaching the sample and the blank control group to the forearm curve of the subject for 24 hours. After removing the patch device, the interval is 30min, the skin reaction is observed after the indentation disappears, and the skin reaction is observed once again after 24h and 48h of the patch test respectively. The grading criteria for adverse skin reactions are shown in Table 1. The result of the patch test can show that the components in the product do not cause adverse reactions such as allergy.
TABLE 1 adverse skin reaction grading
Figure BDA0002511347960000071
Experimental example 2: test for healing Effect of skin injury
General data:
60 subjects using the preparation were observed between 1 month in 2019 and 12 months in 2019, and were randomly divided into 30 subjects (17 men and 13 women) in the test group and 30 subjects (15 men and 15 women) in the control group. The comparative difference of age, sex, burn and scald position, area and other data between two groups has no significance (P is more than 0.05).
The method comprises the following steps:
test groups: (1) debridement and wound surface cleaning: mixing the raw materials in a ratio of 1: the 2000 chlorhexidine solution is used for cleaning and removing wound foreign matter, if blister exists, the blister is firstly drained, and then the wound is flushed by 0.9% physiological saline. (2) The product can be applied directly to wound surface, and can be covered with sterile gauze and bandaged according to the size and position of wound surface, or directly exposed. It is administered in the morning and evening 2 times daily. Wound healing was observed on days 1, 3, 7 and 15, respectively (patients who were cured in the middle of the course could stop using the wound healing agent).
Control group: the debridement method is the same as above, and after drying, a proper amount of iodophor is directly applied to the wound surface, and sterile gauze can be covered on the wound surface according to the size and the position of the wound surface and the wound surface can be bound properly or directly exposed. Similarly, it is administered 2 times daily in the morning and evening. Wound healing was observed on days 1, 3, 7 and 15, respectively (patients who were cured in the middle of the course could stop using the wound healing agent).
Observation indexes are as follows:
(1) comprehensive judgment standard for burn and scald curative effect. And (3) healing: the burn and scald wound surface is completely or basically healed, and clinical symptoms completely disappear. The effect is shown: more than 90% of burn and scald wounds heal, and most clinical symptoms disappear. Effectively, the burn and scald wound surface is partially healed, and partial clinical symptoms are improved. And (4) invalidation: the burn and scald wound surface and clinical symptoms are not improved.
(2) Calculating the wound healing rate: the size of the wound surface is printed on a transparent film on days 1, 3, 7 and 15 respectively, the area of the wound surface is measured and calculated, and then the wound healing rate is calculated. Thereby objectively evaluating the effect. Wherein the formula is as follows: the wound healing rate is (original wound area-unhealed wound area)/original wound area.
(3) Wencouver scar scale (VSS) score: the method is mainly used for evaluating the hyperplastic scar of a patient, and comprises 4 dimensions of scar color, softness, vascularity and thickness, the total score is 15, and the score is higher when the scar is more serious.
The treatment data acquisition strictly follows the statistical principle and is analyzed and processed by software SPSS17.0, and P <0.05 indicates that the difference has statistical significance.
As a result:
1. comparison of the overall therapeutic effects of the two groups
TABLE 2 comparison of the overall efficacy of the two groups of subjects
Figure BDA0002511347960000081
The results in the table show that the total treatment significant efficiency of the test subjects is 93.34%, which is higher than that of the control patients, and the difference is statistically significant (P < 0.05).
2. Comparison of healing time between two groups
TABLE 3 comparison of recovery time of two groups of subjects
Figure BDA0002511347960000082
As can be seen from table 3, the test groups all significantly shortened the time required to heal the patients, and the differences were statistically significant compared to the control group: p < 0.05.
3. General observation of two groups of wound surfaces
TABLE 4 day 1, 3, 7, 15 healing status in two groups of subjects
Figure BDA0002511347960000091
4. Comparison of healing rates of two groups of wounds
TABLE 5 comparison of wound healing rates of two groups
Test group Control group
Day 1 (3.28±2.77)% 0
Day 3 (33.75±1.51)% (16.73±3.57)%
Day 7 (70.86±2.62)% (39.94±2.61)%
Day 15 (95.36±2.50)% (52.63±3.61)%
The results in the table show that the differences of the wound healing rates of the test group and the control group at each time point are significant, and the differences between the time points are significant.
5. Two groups of wound healing scar formation rate scores
TABLE 6 comparison (score) of VSS scores after two groups of treatment
Group of Number of examples Color Softness Vascularity distribution Thickness of
Test group 30 1.42±0.18 1.38±0.16 1.64±0.18 1.50±0.17
Control group 30 1.85±0.21 2.25±0.24 2.01±0.25 1.92±0.22
After 15 days of treatment, the skin color, softness, vascularity and thickness score of the skin wound of the test subjects in the test group are all significantly lower than those of the control group, and the difference has statistical significance (P is less than 0.05).
6. Comparative example before and after wound surface after use
Fig. 1A shows the skin injury after scald, and fig. 1B shows the healing effect of the skin injury after 15 days of using the product of the invention. Therefore, the product of the invention has excellent skin healing effect, no scar and smooth surface.
In conclusion, the product has good healing treatment effect on the burn wound, feels mild, comfortable and not greasy when being used, and can show obvious treatment effect after 2 weeks.
Finally, it should be noted that the above embodiments are only used for illustrating the technical solutions of the present invention and not for limiting the protection scope of the present invention, and although the present invention has been described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.

Claims (5)

1. The exosome preparation for promoting the healing of skin wound surfaces is characterized by being prepared from the following raw materials in parts by mass: 30-50 parts of a dry cell exosome extract, 10-20 parts of a basca flower extracting solution, 10-20 parts of a witch hazel extracting solution, 10-20 parts of a chamomile extracting solution, 0.2-1 part of allantoin, 0.05-1 part of alginate, 1-5 parts of PEG-40 hydrogenated castor oil, 0.05-0.1 part of hyaluronic acid, 1-5 parts of butanediol, 0.1-0.3 part of methyl hydroxybenzoate, 0.1-1 part of hydroxyethyl cellulose, 0.05-0.1 part of EDTA-disodium and 4-33 parts of deionized water;
the stem cell exosome extract comprises mesenchymal stem cell exosomes and mesenchymal stem cell culture supernatant; the preparation method of the stem cell exosome extract comprises the following steps:
(1) carrying out cell culture according to GMP to obtain mesenchymal stem cells;
(2) ultrasonically crushing the mesenchymal stem cells obtained in the step (1) to obtain mesenchymal stem cell exosomes;
(3) collecting the supernatant of the mesenchymal stem cells in the step (1) to obtain a supernatant exosome of the stem cell culture;
(4) respectively dissolving the mesenchymal stem cell exosomes obtained in the step (2) and the stem cell culture supernatant exosomes obtained in the step (3) in normal saline, and mixing and stirring uniformly in equal volume to obtain a stem cell exosome extract;
the preparation method of the basjoo flower extracting solution comprises the following steps:
(1) taking fresh flowers of the ballflower, adding 18 times of 65% ethanol for the first time, and extracting for 1.5 hours; adding 10 times of 60% ethanol for the second time, and extracting for 1.5 hours; adding 8 times of 60% ethanol for the third time, and extracting for 1.5 hr; (2) filtering the extractive solutions extracted for 3 times with gauze, mixing filtrates, and concentrating the filtrate under reduced pressure to 5 times of the weight of flos Bombacis Cannabinae to obtain flos Bombacis Cannabinae extractive solution;
the preparation method of the witch hazel extract comprises the following steps:
(1) taking fresh witch hazel, adding 18 times of 65% ethanol for the first time, and extracting for 1.5 hours; adding 10 times of 60% ethanol for the second time, and extracting for 1.5 hours; adding 8 times of 60% ethanol for the third time, and extracting for 1.5 hr; (2) filtering the extractive solutions extracted for 3 times with gauze, mixing filtrates, and concentrating the filtrate under reduced pressure to 5 times of the weight of flos Bombacis Cannabinae to obtain radix Hamamelis mollis extractive solution;
the preparation method of the chamomile extracting solution comprises the following steps:
(1) taking fresh chamomile, adding 18 times of 65% ethanol for the first time, and extracting for 1.5 hours; adding 10 times of 60% ethanol for the second time, and extracting for 1.5 hours; adding 8 times of 60% ethanol for the third time, and extracting for 1.5 hr; (2) filtering the extractive solutions extracted for 3 times with gauze, mixing filtrates, and concentrating the filtrate under reduced pressure to 5 times of the weight of flos Bombacis Cannabinae to obtain flos Matricariae Chamomillae extractive solution;
the exosome preparation is applied to preparation of products for treating burns and scalds.
2. A preparation of exosomes for promoting healing of cutaneous wounds according to claim 1, characterised in that: 40 parts of dry cell exosome extract, 15 parts of basjoo flower extract, 15 parts of witch hazel extract and 15 parts of chamomile extract.
3. A preparation of exosomes for promoting healing of cutaneous wounds according to claim 1, characterised in that: 0.5 part of allantoin, 0.05 part of alginate, 5 parts of PEG-40 hydrogenated castor oil, 0.05 part of hyaluronic acid, 4 parts of butanediol, 0.1 part of methyl hydroxybenzoate, 0.5 part of hydroxyethyl cellulose, 0.05 part of EDTA-disodium and 4.75 parts of deionized water.
4. The exosome preparation for promoting skin wound healing according to claim 1, wherein the alginate is at least one of sodium alginate, potassium alginate, calcium alginate and ammonium alginate.
5. A method of preparing an exosome preparation for promoting skin wound healing according to any one of claims 1 to 4, characterised by comprising the steps of:
s1 dissolving allantoin, alginate, hyaluronic acid and EDTA-disodium in deionized water, and stirring;
s2, adding butanediol, methyl hydroxybenzoate and hydroxyethyl cellulose into the solution obtained in the step S1 in proportion, and stirring and mixing uniformly;
s3, adding the basjoo flower extracting solution, the witch hazel extracting solution, the chamomile extracting solution and the PEG-40 hydrogenated castor oil into the solution obtained in the step S2 according to a proportion, and stirring and mixing uniformly;
s4 adding the extract of the stem cell exosome into the solution obtained in the step S3 according to a certain proportion, and stirring and mixing uniformly to obtain a finished product.
CN202010462102.0A 2020-05-27 2020-05-27 Exosome preparation for promoting skin wound healing and preparation method thereof Active CN111632075B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010462102.0A CN111632075B (en) 2020-05-27 2020-05-27 Exosome preparation for promoting skin wound healing and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010462102.0A CN111632075B (en) 2020-05-27 2020-05-27 Exosome preparation for promoting skin wound healing and preparation method thereof

Publications (2)

Publication Number Publication Date
CN111632075A CN111632075A (en) 2020-09-08
CN111632075B true CN111632075B (en) 2021-09-07

Family

ID=72323121

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010462102.0A Active CN111632075B (en) 2020-05-27 2020-05-27 Exosome preparation for promoting skin wound healing and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111632075B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112941010A (en) * 2021-01-30 2021-06-11 湖北嘉弘福科技有限责任公司 Plant callus efficacy filtrate and exosome extraction method
CN113018419B (en) * 2021-04-01 2024-06-25 南通大学附属医院 Medical chitosan nanoparticle for wound repair and scar inhibition and preparation method thereof
CN115177782B (en) * 2021-04-02 2023-07-18 诺一迈尔(山东)医学科技有限公司 Liquid band-aid with high air permeability and healing promotion function and preparation method thereof
CN112972368A (en) * 2021-04-19 2021-06-18 哈尔滨医科大学 Pharmaceutical composition for promoting healing of postoperative wound surface of anorectal surgery and preparation method thereof
CN114939098B (en) * 2022-05-19 2023-09-26 明德南加(成都)生物技术有限公司 Exosome-loaded hydrogel and preparation method and application thereof
CN115300537A (en) * 2022-10-09 2022-11-08 广州赛琅生物技术有限公司 Medicine for treating vaginitis, gel containing medicine and preparation method of gel
CN116036247B (en) * 2023-02-03 2024-04-05 江中药业股份有限公司 Composition for inhibiting inflammatory response, promoting angiogenesis and wound healing and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108853145A (en) * 2017-09-11 2018-11-23 江苏国立生物研究院有限公司 Application of the excretion body of mescenchymal stem cell secretion in biological agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108853145A (en) * 2017-09-11 2018-11-23 江苏国立生物研究院有限公司 Application of the excretion body of mescenchymal stem cell secretion in biological agent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
鸡蛋花总黄酮的提取及其面膜液的制备;邓金生等;《广东化工》;20190731;第46卷(第14期);第20、28-29页 *

Also Published As

Publication number Publication date
CN111632075A (en) 2020-09-08

Similar Documents

Publication Publication Date Title
CN111632075B (en) Exosome preparation for promoting skin wound healing and preparation method thereof
CN106822988B (en) Alginate fiber functional dressing and application thereof, and alginate fiber functional dressing patch
CN107184961A (en) A kind of competent cell renovation agent and preparation method thereof
CN112089883B (en) Medical cold compress dressing and preparation method thereof
CN103083712A (en) Stem cells or other bioactive substances doped surgical dressing
CN109700998A (en) A kind of compound skin injury regeneration renovation agent and preparation method thereof
CN107441479B (en) Marine active peptide/chitin burn ointment for treating scald and preparation method thereof
KR102249700B1 (en) Comsmetic composition comprising mint vinegar
CN111012945B (en) Waterproof traditional Chinese medicine liquid band-aid and preparation method thereof
CN110123953B (en) Cold compress patch for promoting postoperative skin repair and preparation method thereof
CN111686206A (en) Moisturizing and repairing bacterial cellulose mask and preparation method thereof
CN108078868B (en) Antiallergic composition for skin care products
WO2013182551A1 (en) Saccharide fraction from wheat, isolation process and field of use of the invention
CN109731040A (en) A kind of wound remediation composition, preparation method and applications
CN101822827A (en) Preparation for cosmetic dermatology and scar repairing
CN115501385A (en) Wound film-forming dressing for promoting wound healing and preparation method thereof
CN112121146B (en) A topical gel for treating skin wound, and its preparation method
CN113577172A (en) Traditional Chinese medicine external cream for treating diabetic foot and preparation method and application thereof
CN112245332A (en) Eczema gel containing marine oligosaccharide
CN111166794A (en) A Chinese medicinal composition for treating gynecological diseases
CN111514119A (en) Adhesive bandage containing industrial hemp root extract and preparation method thereof
CN112023110A (en) Active antibacterial dressing based on bamboo fungus egg extract
CN114886927B (en) Five-cereal insect active ingredient composition and preparation method and application thereof
CN115463077A (en) Firming and repairing essence and preparation method thereof
CN118286491A (en) Preparation process and application of ganoderma lucidum flavone

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant